MindAffect, founded in 2017, is at the cutting edge of BCI/AI HealthTech Innovations for diagnostics and communication. Specializing in both AI and IT sectors, this The Netherlands-based neuroscience healthtech company focuses on developing advanced hearing and vision diagnostic systems.
Marking a significant milestone, MindAffect recently secured a €230.00K Series A investment in June 2024 from Health Venture. This financial endorsement underscores investor confidence in their potential to revolutionize diagnostic technology.
With its innovative approach and a promising position in the healthtech industry, MindAffect presents a compelling opportunity for investors seeking to tap into the burgeoning intersection of AI and healthcare solutions.